Portugal Sets Record for Obesity Drug Sales
Portugal’s prescription obesity drug sales hit a historic high, with 528,000 packs sold in the first six months of 2026 and daily spending reaching €731,000.
📌 Key Highlights & Context
- 528,000 packs sold in first half of 2026
- Daily spend hit €731,000
- Mounjaro accounts for 75% of sales
Record Sales Figures
Half‑year sales reached 528,000 packs, matching the entire 2025 volume in just six months.
Economic Impact
Total revenue topped €132 million, with an average daily spend of €731,000.
- Injectable tirzepatide (Mounjaro) represents 75% of sales.
- Average pack price is €283.